Abstract:Background: Hyperhomocysteinemia (HHcy) is related to liver diseases, such as nonalcoholic fatty liver (NAFL). Although the precise pathogenesis of NAFL is still largely unknown, the links between organs seem to play a vital role. The current study aimed to explore the role of white adipose tissue in homocysteine (Hcy)-induced NAFL. Methods: Blood samples from nonhyperhomocysteinemia or hyper-homocysteinemia individuals were collected to assess correlation between Hcy and TG or FFAs levels. C57BL/6 mice were maintained on a high-methionine diet or administered with Hcy (1.8 g/l) in the drinking water to establish an HHcy mouse model. Lipolytic response was measured in adipose tissue or 3T3L-1 cells. Hif1a∆adipo mice and lentivirus construction were employed for mechanistic studies. Findings: We demonstrated that Hcy activated adipocyte lipolysis and that this change was accompanied by an increased release of fatty acids (FAs) and glycerol. Excessive FAs were taken up by hepatocyte, which resulted in lipid accumulation in the liver. Treatment with acipimox (0.08 g kg −1 day−1), a potent chemical inhibitor of lipolysis, markedly decreased the Hcy-induced NAFL. Mechanistically, hypoxia-inducible factor 1α (HIF1α)-endoplasmic reticulum oxidoreductin 1α (ERO1α) mediated pathway promoted ROS accumulation and induced ER overoxidation, ER stress and more closed ER-lipid droplet interactions, which were responsible for activating the lipolysis response. Specific disruption of adipocyte HIF1α reversed Hcy-induced lipolysis and alleviated the excess hepatic TG content. Interpretation: This study reveals that Hcy activates lipolysis via adipocyte HIF1α-ERO1α-mediated pathway and suggests the potential utility of targeted adipocyte HIF1α inhibition for treating Hcy-induced NAFL. Funding Statement: This work was supported by the National Natural Science Foundation of the People’s Republic of China (No. 31872787, 91739303, 91857115, 31925021, and 31771261) and the Youth Innovation Promotion Association, CAS (to LW). Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: Plasma was obtained from 38 individuals with hyperhomocysteinemia and 52 nonhyperhomocysteinemia from Peking University Third Hospital and was approved by the Ethics Committee of Peking University Third Hospital. Informed consent prior to participation was provided by all subjects. All animal studies were performed in compliance with the guidelines of the Institute of Laboratory Animal Resources and were approved by the Animal Care and Use Committee of Peking University.

Homocysteine activates autophagy by inhibition of CFTR expression via interaction between DNA methylation and H3K27me3 in mouse liver

Homocysteine accelerates hepatocyte autophagy by upregulating TFEB via DNMT3b-mediated DNA hypomethylation

Homocysteine facilitates endoplasmic reticulum stress and apoptosis of hepatocytes by suppressing ERO1α expression via cooperation between DNMT1 and G9a

[Homocysteine Promotes Human Hepatocyte Autophagy Through Activating the Activating Molecule in Beclin-1-regulated Autophage (AMBRA1)].

CFTR suppressing hyperhomocysteinemia-induced hepatocyte damage in ApoE-/-mice

Folate Protects Hepatocytes of Hyperhomocysteinemia Mice from Apoptosis Via Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)-Activated Endoplasmic Reticulum Stress

Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner

Homocysteine induces human mesangial cell apoptosis via the involvement of autophagy and endoplasmic reticulum stress

Homocysteine Up-Regulates ETB Receptors Via Suppression of Autophagy in Vascular Smooth Muscle Cells

Mir‐34a Targets HDAC1‐Regulated H3K9 Acetylation on Lipid Accumulation Induced by Homocysteine in Foam Cells

Homocysteine Promotes Hepatic Steatosis by Activating the Adipocyte HIF1α-ERO1α-Lipolysis Pathway

Hyperhomocysteinemia in Apoe-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 Via Mir-92a Regulation

Hyperhomocysteinemia-mediated DNA Hypomethylation and Its Potential Epigenetic Role in Rats.

Homocysteine Triggers Inflammatory Responses in Macrophages Through Inhibiting CSE-H2S Signaling Via DNA Hypermethylation of CSE Promoter

Homocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes

Impaired Autophagy Mediates Hyperhomocysteinemia-Induced HA-VSMC Phenotypic Switching

Homocysteine promotes cardiac fibrosis by regulating the Akt/FoxO3 pathway

HMGB1-induced Autophagy Facilitates Hepatic Stellate Cells Activation: a New Pathway in Liver Fibrosis

Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor/cd36 Pathway to Promote Hepatic Steatosis in Mice

Hyperhomocysteinemia Induces Cardiac Injury by Up-Regulation of P53-Dependent Noxa and Bax Expression Through the P53 DNA Methylation in ApoE(-/-) Mice.

Homocysteine Activates T Cells by Enhancing Endoplasmic Reticulum-Mitochondria Coupling and Increasing Mitochondrial Respiration.